key: cord-0842721-ujm7h1sb
authors: Schimpf, Judith; Sprenger-Mähr, Hannelore; Davidovic, Tamara; Lhotta, Karl; Zitt, Emanuel
title: Humoral Response in SARS-CoV-2 Convalescent Compared to Vaccinated Kidney Transplant Patients
date: 2022-01-18
journal: Transpl Int
DOI: 10.3389/ti.2021.10060
sha: de92e407c0565105fa454c70e05ad9d1c9882441
doc_id: 842721
cord_uid: ujm7h1sb

nan

fight respiratory viral diseases. These considerations and first experience showing a 49-70% humoral response rate after a third vaccine dose in kidney transplant patients without seroconversion after two doses (6-8) support an early third vaccination to improve the seroconversion rate in this vulnerable population.

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements. The patients/participants provided their written informed consent to participate in this study.

JS, HS-M, KL, and EZ designed the study, JS, HS-M, and TD collected data, JS and EZ analyzed data and wrote the first draft of the manuscript. All authors reviewed the manuscript approved the submitted version of the manuscript.

Results from the ERA-EDTA Registry Indicate a High Mortality Due to COVID-19 in Dialysis Patients and Kidney Transplant Recipients across Europe

COVID-19 Infection in Solid Organ Transplant Recipients after SARS-CoV-2 Vaccination

Low Immunization Rates Among Kidney Transplant Recipients Who Received 2 Doses of the mRNA-1273 SARS-CoV-2 Vaccine

Humoral Response to SARS-CoV-2 Is Well Preserved and Symptom Dependent in Kideny Transplant Recipients

Superior Cellular and Humoral Immunity toward SARS-CoV-2 Reference and Alpha and Beta VOC Strains in COVID-19 Convalescent as Compared to the Prime Boost BNT162b2 Vaccinated Dialysis Patients

A Third Vaccine Dose Substantially Improves Humoral and Cellular SARS-CoV-2 Immunity in Renal Transplant Recipients with Primary Humoral Nonresponse

A Third Injection of the BNT162b2mRNA COVID-19 Vaccine in Kidney Transplant Recipients Improves the Humoral Immune Response

Antibody Response after Athird Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients with Minimal Seologic Response to 2 Doses

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The Supplementary Material for this article can be found online at: https://www.frontierspartnerships.org/articles/10.3389/ti.2021. 10060/full#supplementary-material